Funder
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Management of Technology and Innovation,Health Policy,Issues, ethics and legal aspects,Health (social science)
Reference36 articles.
1. Allhoff, F. (2005). Germ-line genetic enhancement and Rawlsian primary goods. Kennedy Institute of Ethics Journal, 15(1), 39–56. https://doi.org/10.5840/jpr_2007_8.
2. Baylis, F. (2016). ‘Broad societal consensus’ on human germline editing. Harvard Health Policy Review, 15(2), 19–23.
3. Baylis, F., & Robert, J. S. (2004). The inevitability of genetic enhancement technologies. Bioethics, 18(1), 1–26. https://doi.org/10.1111/j.1467-8519.2004.00376.x.
4. Beauchamp, T. L., & Childress, J. F. (2013). Principles of biomedical ethics (7th ed.). New York: Oxford University Press.
5. Cyranoski, D. (2019). Russian biologist plans more CRISPR-edited babies. Nature, 2019(570), 7760.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献